Form 8-K PROTEON THERAPEUTICS For: Aug 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Proteon Therapeutics (PRTO) Reports Q2 Loss of $0.31/Share
August 13, 2015 5:16 PM EDTProteon Therapeutics (NASDAQ: PRTO) reported Q2 EPS of ($0.31), versus ($18.55) reported last year.
Cash, cash equivalents and available-for-sale investments totaled $74.7 million as of June 30, 2015, compared to $83.6 million as of December 31, 2014. The decrease was driven by operational costs for the first six-month period of... More
